OLA Blog

STEM CELL RESEARCH AND ETHICS

Written by Meguid El Nahas on Wednesday, 30 July 2014. Posted in OLA Blog

STEM CELL RESEARCH AND ETHICS
This month in the Lancet: An editorial by Farhat Yaqub on: Rana Dajani and teh Ethics of Stem cell Research in the Middle East. http://www.ncbi.nlm.nih.gov/pubmed/25066151 The editorial highlights Dr Rana Dajani elevated position in medical...

NICE NEW CKD GUIDELINES: A DAMP SQUIB?

Written by Meguid El Nahas on Wednesday, 30 July 2014. Posted in OLA Blog

NICE NEW CKD GUIDELINES: A DAMP SQUIB?
PROFESSOR RICHARD GLASSOCK WROTE: New NICE CKD Guidelines On July 23, 2014 the National Institute for Health and Care Excellence (NICE) of the United Kingdom released its new 2014 guidance for Chronic Kidney Disease (CKD). This new version...

mTOR inhibition and Anti-Phospholipid Syndrome

Written by arif khwaja on Thursday, 24 July 2014. Posted in OLA Blog

mTOR inhibition and Anti-Phospholipid Syndrome
High impact journals tend to focus on clinical trial data that are likely to impact on practice. So it was nice to see a very simple but elegant piece of ‘bench to bedside’ work published in this weeks’ NEJM from Canaud and...

CKD after Kidney Donation...

Written by Meguid El Nahas on Wednesday, 16 July 2014. Posted in OLA Blog

CKD after Kidney Donation...
Experiences Obtaining Insurance After Live Kidney Donation Written by AJT on Wednesday, 16 July 2014. The impact of kidney donation on the ability to change or initiate health or life insurance following donation is unknown. To...

BEWARE OF SPREADSHEET NEPHROLOGISTS!

Written by Meguid El Nahas on Thursday, 12 June 2014. Posted in OLA Blog

BEWARE OF SPREADSHEET NEPHROLOGISTS!
Nephrology practice, research and publications seem to have been highjacked by spreadhseet nephrologists and biostatisticians who are changing the face of Nephrology and its practice. They have created a bubble with CKD…; global epidemic...

The delusion of eGFR!

Written by Meguid El Nahas on Tuesday, 10 June 2014. Posted in OLA Blog

The delusion of eGFR!
J Am Soc Nephrol. 2014 Apr;25(4):810-8. doi: 10.1681/ASN.2013050557. Epub 2013 Dec 5. Longitudinal changes in estimated and measured GFR in type 1 diabetes. de Boer IH1, Sun W, Cleary PA, Lachin...

THE LOCH NESS MONSTER OF NEPHROLOGY: UREMIC TOXINS...

Written by Meguid El Nahas on Thursday, 05 June 2014. Posted in OLA Blog

THE LOCH NESS MONSTER OF NEPHROLOGY: UREMIC TOXINS...
DR SAMAH IDRISS REPORTED FROM EDAT-ERA 2014: EUROTOX GRAND SESSIONPROF R Vanholder and G. GlorieuxUremic toxins are more like established Gut Kidney axis with effect on mechanisms with impact on survival and quality of life of CKD patients...

IRON CHELATORS OF PHOSPHATE: FROM EDTA

Written by Meguid El Nahas on Thursday, 05 June 2014. Posted in OLA Blog

IRON CHELATORS OF PHOSPHATE: FROM EDTA
PROFESSOR PIERRE DELANAYE WROTE FROM THE EDTA-ERA CONGRESS IN AMSTERDAM: Le Docteur Block, bien connu pour ses nombreuses études dans le domaine CKD-MBD, a montré les premiers résultats avec un nouveau chélateur...

LIVE FROM AMSTERDAM WITH PIERRE DELANAYE

Written by Meguid El Nahas on Monday, 02 June 2014. Posted in OLA Blog

LIVE FROM AMSTERDAM WITH PIERRE DELANAYE
PROF PIERRE DELANAYE REPORTED FROM AMSETRDAM: PROF DELANAYE REPORTING FROM EDTA IN FRENCH AND TRANSLATED BY GOOGLE:Dr. Roussel presented safety data on a molecule studied in type 2 diabetes : the canagliflozine (CANA ) . It is an inhibitor of the...

LIVE FROM EDTA-ERA AMSTERDAM 2014

Written by Meguid El Nahas on Monday, 02 June 2014. Posted in OLA Blog

LIVE FROM EDTA-ERA AMSTERDAM 2014
PROFESSOR PIERRE DELANAYE REPORTING IN FRENCH: Le docteur Warnock nous a brillamment présenté les résultats d’une analyse de la cohorte REGARDS, bien connue de tous. Son idée, simple, est la suivante. Les...